Zoomlion to Build Smart Factory for Aerial Work Platforms in Hungary

2025-02-25 Zoomlion HaiPress

BUDAPEST,Hungary,Feb. 21,2025 --On February 21,2025,Zoomlion Heavy Industry Science & Technology Co.,Ltd. ("Zoomlion") announced its plan to establish a modern smart factory for aerial work platforms in Hungary. The project,formalized through an agreement signed on Feb. 20,was highlighted at a press conference hosted by the Minister of Foreign Affairs and Trade of Hungary.


Press Conference Announcing Zoomlion's Aerial Work Platform Project in Hungary

Strategically located in Tatabánya at the intersection of major highway networks,the factory will serve as a vital hub linking Eastern and Western Europe's key logistics routes. Once operational,it is expected to significantly strengthen Zoomlion's presence in the European aerial work platform sector.

With a total area of approximately 250 mu (approximately 41.18 acres),the factory will be jointly developed by Zoomlion and CTP Group. The facility will be equipped with advanced intelligent,digital,and environmentally sustainable production technologies to manufacture a wide range of high-performance,premium-quality,and low-carbon aerial work platforms. By leveraging cutting-edge production processes and equipment,the facility will be better positioned to serve both local and European markets.

Once operational,the project is expected to create 800 local job opportunities,fostering economic growth and employment in the region. It will also strengthen collaboration with local supply chain partners,enhance synergy with local businesses,and actively cultivate a localized industrial ecosystem through a closely integrated,mutually beneficial partnership,further contributing to Hungary's economic and social development.

In recent years,Zoomlion has been actively advancing its global business strategy through a "global village" mindset and a localized operational approach. The company has established 10 overseas R&D and manufacturing bases,with products sold in over 150 countries and regions. More than 50% of Zoomlion's revenue now comes from markets outside China.

"We'd like to extend our sincere gratitude to all parties who have supported this project," stated Zhan Chunxin,Chairman and CEO of Zoomlion. "We will accelerate project implementation according to the investment strategy,and bring the factory into operation in this year."

Disclaimer: This article is reproduced from other media. The purpose of reprinting is to convey more information. It does not mean that this website agrees with its views and is responsible for its authenticity, and does not bear any legal responsibility. All resources on this site are collected on the Internet. The purpose of sharing is for everyone's learning and reference only. If there is copyright or intellectual property infringement, please leave us a message.

Newest

1Cangxi County Holds 2026 New Year's Cultural Performance for the Public

Cangxi County Holds 2026 New Year's Cultural Performance for the Public

2The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

3The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

4Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

5Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

6Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

©copyright 2009-2020 Singapore Info Map